Changes in BMI in CML patients during therapy with imatinib
| BMI . | Months after imatinib therapy . | ||||
|---|---|---|---|---|---|
| 0 . | 6 . | 12 . | 18 . | 24 . | |
| Non-obese | 36 (80%) | 29 (68%) | 27 (68%) | 22 (56%) | 19 (58%) |
| Obese | 9 (20%) | 14 (32%) | 13 (32%) | 17 (44%) | 14 (42%) |
| P value comparison with time 0 | .18 | .19 | .02 | .03 | |
| BMI . | Months after imatinib therapy . | ||||
|---|---|---|---|---|---|
| 0 . | 6 . | 12 . | 18 . | 24 . | |
| Non-obese | 36 (80%) | 29 (68%) | 27 (68%) | 22 (56%) | 19 (58%) |
| Obese | 9 (20%) | 14 (32%) | 13 (32%) | 17 (44%) | 14 (42%) |
| P value comparison with time 0 | .18 | .19 | .02 | .03 | |
BMI indicates body mass index.